Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 1
1983 1
1984 1
1985 1
1986 3
1991 1
1992 3
1994 1
1995 2
1997 4
1999 1
2000 1
2001 1
2002 1
2004 2
2005 2
2006 1
2007 2
2008 1
2009 3
2010 1
2011 2
2013 4
2014 3
2016 2
2017 2
2018 5
2020 2
2021 4
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Results by year
Filters applied: . Clear all The following terms were ignored: %, %, % The following terms were not found in PubMed: 20RH, 5BAuthor
Page 1
5D whole-heart sparse MRI.
Feng L, Coppo S, Piccini D, Yerly J, Lim RP, Masci PG, Stuber M, Sodickson DK, Otazo R. Feng L, et al. Magn Reson Med. 2018 Feb;79(2):826-838. doi: 10.1002/mrm.26745. Epub 2017 May 11. Magn Reson Med. 2018. PMID: 28497486 Free PMC article.
Quantitative coronary sharpness and length were always better for the 5D images. Good agreement was obtained for quantification of cardiac function compared with 2D cine imaging. CONCLUSION: 5D whole-heart sparse imaging represents a robust and promising framework f …
Quantitative coronary sharpness and length were always better for the 5D images. Good agreement was obtained for quantification of ca …
Is "less than 5 by 35" still achievable?
Hagen L, Schwartz R. Hagen L, et al. Health Promot Chronic Dis Prev Can. 2021 Oct;41(10):288-291. doi: 10.24095/hpcdp.41.10.03. Health Promot Chronic Dis Prev Can. 2021. PMID: 34668683 Free PMC article. No abstract available.
Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).
Hanna M, Damy T, Grogan M, Stewart M, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS. Hanna M, et al. Am J Cardiol. 2021 Feb 15;141:98-105. doi: 10.1016/j.amjcard.2020.10.066. Epub 2020 Nov 19. Am J Cardiol. 2021. PMID: 33220323 Free article. Clinical Trial.
Change in Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) domain scores, EQ-5D-3L scores, and patient global assessment, were prespecified exploratory end points. ...Tafamidis significantly reduced the decline in all 4 KCCQ-OS domains (p <0.0001 for a …
Change in Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) domain scores, EQ-5D-3L scores, and patient global asses …
Response-shift effects in neuromyelitis optica spectrum disorder: estimating response-shift-adjusted scores using equating.
Schwartz CE, Stark RB, Stucky BD, Li Y, Rapkin BD. Schwartz CE, et al. Qual Life Res. 2021 May;30(5):1283-1292. doi: 10.1007/s11136-020-02727-8. Epub 2021 Jan 5. Qual Life Res. 2021. PMID: 33398520 Free PMC article.
BACKGROUND: In our companion paper, random intercept models (RIMs) investigated response-shift effects in a clinical trial comparing Eculizumab to Placebo for people with neuromyelitis optica spectrum disorder (NMOSD). RIMs predicted Global Health using the EQ-5D Visual An …
BACKGROUND: In our companion paper, random intercept models (RIMs) investigated response-shift effects in a clinical trial comparing Eculizu …
CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
Cardinaud S, Consiglieri G, Bouziat R, Urrutia A, Graff-Dubois S, Fourati S, Malet I, Guergnon J, Guihot A, Katlama C, Autran B, van Endert P, Lemonnier FA, Appay V, Schwartz O, Kloetzel PM, Moris A. Cardinaud S, et al. PLoS Pathog. 2011 May;7(5):e1002049. doi: 10.1371/journal.ppat.1002049. Epub 2011 May 12. PLoS Pathog. 2011. PMID: 21589903 Free PMC article.
Proviruses encoding Q9VF/5D were significantly less represented in HLA-B*07+ than in HLA-B*07- patients, suggesting that Q9FV/5D encoding viruses might be under selective pressure in HLA-B*07+ individuals. ...As expected, cells infected with HIV strains encoding for …
Proviruses encoding Q9VF/5D were significantly less represented in HLA-B*07+ than in HLA-B*07- patients, suggesting that Q9FV/5D …
Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH, Pickard AS, Xie F, Walton SM, Lee TA, Schwartz A. Law EH, et al. Med Decis Making. 2018 Nov;38(8):968-982. doi: 10.1177/0272989X18802797. Med Decis Making. 2018. PMID: 30403577
OBJECTIVE: To compare and contrast EQ-5D-5L (5L) and EQ-5D-3L (3L) health state values derived from a common sample. METHODS: Data from the 2017 US EQ-5D valuation study were analyzed. Value sets were estimated with random-effects linear regression based on c …
OBJECTIVE: To compare and contrast EQ-5D-5L (5L) and EQ-5D-3L (3L) health state values derived from a common sample. METHODS: …
Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study.
Lumry WR, Weller K, Magerl M, Banerji A, Longhurst HJ, Riedl MA, Lewis HB, Lu P, Devercelli G, Jain G, Maurer M; HELP Study Investigators. Lumry WR, et al. Allergy. 2021 Apr;76(4):1188-1198. doi: 10.1111/all.14680. Epub 2020 Dec 24. Allergy. 2021. PMID: 33258114 Free PMC article. Clinical Trial.
The Angioedema Quality of Life Questionnaire (AE-QoL) was administered monthly, consisting of four domain (functioning, fatigue/mood, fears/shame, nutrition) and total scores. The generic EQ-5D-5L questionnaire was administered on days 0, 98, and 182. Comparisons were made …
The Angioedema Quality of Life Questionnaire (AE-QoL) was administered monthly, consisting of four domain (functioning, fatigue/mood, fears/ …
Time-Specific Differences in Stated Preferences for Health in the United States.
Law EH, Pickard AS, Walton SM, Xie F, Lee TA, Schwartz A. Law EH, et al. Med Care. 2022 Jun 1;60(6):462-469. doi: 10.1097/MLR.0000000000001714. Epub 2022 Mar 22. Med Care. 2022. PMID: 35315380
OBJECTIVE: The aim was to examine whether stated health preferences are different between 2002 and 2017, controlling for demographic changes in the United States. METHODS: Data from 2002 and 2017 US EQ-5D-3L valuation studies were combined. The primary analysis compared va …
OBJECTIVE: The aim was to examine whether stated health preferences are different between 2002 and 2017, controlling for demographic changes …
Health state utilities among contemporary prostate cancer patients on active surveillance.
Loeb S, Curnyn C, Walter D, Fagerlin A, Siebert U, Mühlberger N, Braithwaite RS, Schwartz MD, Lepor H, Sedlander E. Loeb S, et al. Transl Androl Urol. 2018 Apr;7(2):197-202. doi: 10.21037/tau.2017.03.80. Transl Androl Urol. 2018. PMID: 29732277 Free PMC article.
We then examined utilities among 37 men on AS participating in focus groups between 2015-2016 using the generic EurQol five dimensions questionnaire (EQ-5D-3L) and Patient Oriented Prostate Utility Scale (PORPUS), a PCa-specific instrument. ...The Spearman correlation betw …
We then examined utilities among 37 men on AS participating in focus groups between 2015-2016 using the generic EurQol five dimensions quest …
56 results